Coherus BioSciences, Inc. - Common Stock (CHRS)
0.9464
+0.0391 (4.31%)
Coherus Bio is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic solutions in the field of immunology and oncology
The company specializes in creating high-quality biologics, including biosimilars—products that are similar to already approved biological medicines. With a commitment to advancing patient care, Coherus Bio engages in research and clinical development to address unmet medical needs, aiming to make healthcare more accessible and affordable through its cutting-edge therapies.
Frequently Asked Questions
Is Coherus BioSciences, Inc. - Common Stock publicly traded?
Yes, Coherus BioSciences, Inc. - Common Stock is publicly traded.
What exchange does Coherus BioSciences, Inc. - Common Stock trade on?
Coherus BioSciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Coherus BioSciences, Inc. - Common Stock?
The ticker symbol for Coherus BioSciences, Inc. - Common Stock is CHRS on the Nasdaq Stock Market
What is the current price of Coherus BioSciences, Inc. - Common Stock?
The current price of Coherus BioSciences, Inc. - Common Stock is 0.9464
When was Coherus BioSciences, Inc. - Common Stock last traded?
The last trade of Coherus BioSciences, Inc. - Common Stock was at 4:00 pm EDT on March 20th, 2025
What is the market capitalization of Coherus BioSciences, Inc. - Common Stock?
The market capitalization of Coherus BioSciences, Inc. - Common Stock is 109.04M
How many shares of Coherus BioSciences, Inc. - Common Stock are outstanding?
Coherus BioSciences, Inc. - Common Stock has 115.21M shares outstanding.